Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

[Artículo traducido] El melanoma de tipo nodular pero no los niveles de vitamina D aumenta el riesgo de desarrollar una segunda neoplasia no cutánea en pacientes con un melanoma: estudio observacional de 663 pacientes
[Nodular Type but Not Vitamin D Levels Increases the Risk of Second Primary Cancers in Melanoma Patients: An Observational Study of 663 Patients]

A. Massa, A. Isasi-Fuster, C. Requena, E. Manrique-Silva, R. Kumar, E. Nagore

. 2024 ; 115 (2) : T143-T149. [pub] 20231202

Jazyk xxx, angličtina Země Španělsko

Typ dokumentu pozorovací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007370

BACKGROUND: Vitamin D deficiency associates with the risk of developing many diseases, including cancer. At the molecular level, vitamin D appears to have an antineoplastic effect. However, the role of vitamin D deficiency in cancer pathogenesis remains unelucidated and numerous studies have resulted in discordant results. This study aimed to determine whether vitamin D deficiency during melanoma diagnosis increases the risk of developing non-cutaneous second primary cancers (SPC). MATERIALS AND METHODS: A retrospective study on 663 patients diagnosed with melanoma between 1 January 2011 and 31 October 2022. The effect of each variable on the development of a subsequent non-cutaneous cancer was performed using Kaplan-Meier curves and differences were assessed by log-rank tests. Cox proportional hazard univariate and multivariate models were used to quantify the effect of each variable in the time to develop a non-cutaneous neoplasia. RESULTS: Out of 663 patients, 34 developed a non-cutaneous SPC. There was no statistically significant association between vitamin D levels and non-cutaneous SPC development (log-rank, p=0.761). Age>60 years, stage III/IV, and nodular melanoma subtype were significantly associated with the development of a SPC. After multivariate analysis, only age>60 years (HR 3.4; HR CI 95%: 1.5-7.6) and nodular melanoma subtype (HR 2.2; HR CI 95%: 1.0-4.8) were included in the final model. CONCLUSIONS: Our results suggest that vitamin D deficiency is not associated with an increased risk of developing non-cutaneous SPC in melanoma patients. However, age over 60 years and nodular melanoma subtype increase the risk for non-cutaneous SPC development.

Nodular Type but Not Vitamin D Levels Increases the Risk of Second Primary Cancers in Melanoma Patients: An Observational Study of 663 Patients

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007370
003      
CZ-PrNML
005      
20240423155913.0
007      
ta
008      
240412s2024 sp f 000 0|eng s
009      
AR
024    7_
$a 10.1016/j.ad.2023.10.038 $2 doi
035    __
$a (PubMed)38048949
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng spa
044    __
$a sp
100    1_
$a Massa, A $u Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
245    10
$a [Artículo traducido] El melanoma de tipo nodular pero no los niveles de vitamina D aumenta el riesgo de desarrollar una segunda neoplasia no cutánea en pacientes con un melanoma: estudio observacional de 663 pacientes / $c A. Massa, A. Isasi-Fuster, C. Requena, E. Manrique-Silva, R. Kumar, E. Nagore
246    31
$a Nodular Type but Not Vitamin D Levels Increases the Risk of Second Primary Cancers in Melanoma Patients: An Observational Study of 663 Patients
520    9_
$a BACKGROUND: Vitamin D deficiency associates with the risk of developing many diseases, including cancer. At the molecular level, vitamin D appears to have an antineoplastic effect. However, the role of vitamin D deficiency in cancer pathogenesis remains unelucidated and numerous studies have resulted in discordant results. This study aimed to determine whether vitamin D deficiency during melanoma diagnosis increases the risk of developing non-cutaneous second primary cancers (SPC). MATERIALS AND METHODS: A retrospective study on 663 patients diagnosed with melanoma between 1 January 2011 and 31 October 2022. The effect of each variable on the development of a subsequent non-cutaneous cancer was performed using Kaplan-Meier curves and differences were assessed by log-rank tests. Cox proportional hazard univariate and multivariate models were used to quantify the effect of each variable in the time to develop a non-cutaneous neoplasia. RESULTS: Out of 663 patients, 34 developed a non-cutaneous SPC. There was no statistically significant association between vitamin D levels and non-cutaneous SPC development (log-rank, p=0.761). Age>60 years, stage III/IV, and nodular melanoma subtype were significantly associated with the development of a SPC. After multivariate analysis, only age>60 years (HR 3.4; HR CI 95%: 1.5-7.6) and nodular melanoma subtype (HR 2.2; HR CI 95%: 1.0-4.8) were included in the final model. CONCLUSIONS: Our results suggest that vitamin D deficiency is not associated with an increased risk of developing non-cutaneous SPC in melanoma patients. However, age over 60 years and nodular melanoma subtype increase the risk for non-cutaneous SPC development.
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    12
$a melanom $x epidemiologie $x etiologie $x diagnóza $7 D008545
650    _2
$a vitamin D $x škodlivé účinky $7 D014807
650    _2
$a retrospektivní studie $7 D012189
650    12
$a sekundární malignity $x epidemiologie $x etiologie $7 D016609
650    12
$a nádory kůže $x etiologie $x komplikace $7 D012878
650    12
$a nedostatek vitaminu D $x komplikace $x epidemiologie $7 D014808
655    _2
$a pozorovací studie $7 D064888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Isasi-Fuster, A $u Facultad de Medicina, Universidad Católica de Valencia San Vicente Mártir, València, Spain
700    1_
$a Requena, C $u Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, València, Spain
700    1_
$a Manrique-Silva, E $u Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, València, Spain
700    1_
$a Kumar, R $u Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany; Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Nagore, E $u Facultad de Medicina, Universidad Católica de Valencia San Vicente Mártir, València, Spain; Servicio de Dermatología, Fundación Instituto Valenciano de Oncología, València, Spain. Electronic address: eduardo.nagore@ucv.es
773    0_
$w MED00000151 $t Actas dermo-sifiliográficas $x 1578-2190 $g Roč. 115, č. 2 (2024), s. T143-T149
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38048949 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155910 $b ABA008
999    __
$a ok $b bmc $g 2081380 $s 1217137
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 115 $c 2 $d T143-T149 $e 20231202 $i 1578-2190 $m Actas dermo-sifiliográficas $n Actas Dermosifiliogr $x MED00000151
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...